Immediate Impact
1 from Science/Nature 74 standout
Citing Papers
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
2023 Standout
Works of V. Stallings being referenced
Targeting dietary fat or glycemic load in the treatment of obesity and type 2 diabetes: A randomized controlled trial
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| V. Stallings | 226 | 56 | 92 | 90 | 15 | 414 | |
| Tenna Ruest Haarmark Nielsen | 208 | 51 | 93 | 123 | 22 | 411 | |
| Iwona Palczewska | 166 | 47 | 100 | 92 | 15 | 454 | |
| Ewelina Napieralska | 215 | 56 | 108 | 92 | 8 | 437 | |
| J. Deutscher | 129 | 58 | 52 | 89 | 17 | 454 | |
| Elena Sergeyev | 194 | 21 | 120 | 95 | 11 | 454 | |
| J. M. Garagorri | 263 | 41 | 83 | 145 | 12 | 457 | |
| Cole D. Bendor | 168 | 36 | 120 | 85 | 15 | 481 | |
| Ghufran Babar | 154 | 92 | 40 | 118 | 9 | 445 | |
| Maria Giulia Berioli | 97 | 42 | 49 | 44 | 12 | 434 | |
| Christine Frithioff‐Bøjsøe | 152 | 50 | 87 | 153 | 29 | 503 |
All Works
Loading papers...